Hamid Trimech | Business Development
ARCALIS, Inc.

Hamid Trimech, Business Development, ARCALIS, Inc.

Hamid Trimech is a Process Engineer with over 10 years of experience in GMP facility construction, technology transfers and vaccine manufacturing. He is currently Project Manager in Business Development at ARCALIS Inc., a Japan-based CDMO specialized in mRNA therapeutics and vaccines. Hamid began his career at Sanofi Pasteur in France, where he contributed to multiple vaccine drug substance projects. Over the past decade, he has contributed to more than 15 vaccine manufacturing projects in Europe, Asia, and Latin America. At ARCALIS, he initially led engineering and MSAT activities, overseeing facility design and construction, mRNA/LNP drug substance and drug product technology transfer and process validation. Notably, he played a key role in the tech transfer of two COVID-19 vaccines in Japan, a recombinant protein-based vaccine and a self-amplifying mRNA (Sa-mRNA) vaccine. He now focuses on client engagement and global project coordination, supporting biotech and pharmaceutical clients from early development to GMP manufacturing.

Appearances:



Day 1 - Tuesday 14th October @ 15:00

Self-Amplifying mRNA vaccine and Pandemic Readiness in Japan

Session led by: ARCALIS, Inc.
last published: 06/Aug/25 15:15 GMT

back to speakers

Get involved at World Vaccine Congress Europe 2025

 

 

TO SPONSOR


Christian Larsmon

Christian.Larsmon@terrapinn.com

 

Otto Squire
Otto.Squire@terrapinn.com

 

TO SPEAK


Isla Sutherland

Isla.Sutherland@terrapinn.com

 

MARKETING & PRESS


Jasper Cameron

Jasper.Cameron@terrapinn.com

 

Stay Up-to-Date

Join our mailing list to receive exclusive content and offers.

By submitting, you agree to receive email communications from Terrapinn, including upcoming promotions and discounted tickets and news.